Released Title Price Sensitive Download Types
2022-01-05 08:23:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/68b4f992386bb08378057895bdcebb58
    Change in substantial holding
2022-01-25 08:18:00 Immutep Quarterly Activities Report and Appendix 4C 1 https://app.sharelinktechnologies.com/announcement/asx/4a3e6c13c5558961ad5dbd389b23b90d
    Commitments Test Entity - Second Quarter Report
    Commitments Test Entity - Second Quarter Activity Report
2022-01-31 10:40:00 Immutep to present at February Investor Conferences 0 https://app.sharelinktechnologies.com/announcement/asx/6cfa770eaced730dcaecc031b49fe364
    Company Administration - Other
2022-02-02 08:18:00 Death of Director Grant Chamberlain 0 https://app.sharelinktechnologies.com/announcement/asx/084abc62060998f4ee955bee9699a68c
    Director Appointment/Resignation
    Company Administration - Other
2022-02-02 08:25:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/2e5993101c8054e77ec6bb305e5790c1
    Change in substantial holding
2022-02-11 11:58:00 Australian Patent Granted for Efti with PD-1 Inhibitors 1 https://app.sharelinktechnologies.com/announcement/asx/edb563fd051e9837debff3b4885379be
    Progress Report
2022-02-18 08:11:00 Immutep Investor Update 0 https://app.sharelinktechnologies.com/announcement/asx/267f049f95b551f6555fd13c25e3f90c
    Periodic Reports - Other
    Progress Report
2022-02-18 08:13:00 Immutep to present new data from TACTI-002 at ELCC 2022 0 https://app.sharelinktechnologies.com/announcement/asx/66513e4f533788ddf178350a54217c10
    Progress Report
    Company Administration - Other
2022-02-23 18:22:00 Half Yearly Report and Accounts 1 https://app.sharelinktechnologies.com/announcement/asx/92b1c65f465fa6fe77e507baec5c2f26
    Half Yearly Report
    Half Year Audit Review
    Half Year Directors' Statement
    Half Year Accounts
    Half Year Directors' Report
2022-02-24 08:01:00 Immutep to Present at Healthcare Investor Conferences 0 https://app.sharelinktechnologies.com/announcement/asx/76769f5f0d4fb408707b1590d2088296
    Company Administration - Other
    Web Casts
2022-02-25 08:01:00 Appointment of Non-Executive Director 0 https://app.sharelinktechnologies.com/announcement/asx/9eb9d44559534aad168a87d1fcb59112
    Director Appointment/Resignation
2022-02-25 15:42:00 Proposed issue of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/f66d1d338b54bac73d9b6bb732167cdf
    Appendix 3B
2022-02-25 15:51:00 Initial Director's Interest Notice - Lucy Turnbull 0 https://app.sharelinktechnologies.com/announcement/asx/0a703f16a8f58a7ffbc2ec3bd93af617
    Initial Director's Interest Notice
2022-03-10 08:25:00 Immutep receives FDA feedback for Efti development in MBC 1 https://app.sharelinktechnologies.com/announcement/asx/72c93ee8b2c36cf666ea0c3bf8f866dc
    Progress Report
2022-03-11 09:26:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/59fcab3eceef54e1349b09dac66e288e
    Appendix 2A (Application for Quotation of Securities
2022-03-16 08:23:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/a14a5fc69fd1d4cc152de3668ab0391f
    Change in substantial holding
2022-03-18 15:36:00 Japanese patent granted for LAG-3 antibody LAG525 1 https://app.sharelinktechnologies.com/announcement/asx/859892aa1ec22c3b8950aa30127cc13d
    Progress Report
2022-03-18 16:18:00 Immutep to present Phase IIb breast cancer data at ESMO 2022 0 https://app.sharelinktechnologies.com/announcement/asx/dde143d416db2c042f0838caad3833b4
    Progress Report
    Company Administration - Other
2022-03-24 08:19:00 Immutep announces publication of ELCC 2022 abstract 1 https://app.sharelinktechnologies.com/announcement/asx/f0f17323fab7806b18a36721790fd2e4
    Progress Report
2022-03-30 08:24:00 Efti with Keytruda shows encouraging activity in lung cancer 1 https://app.sharelinktechnologies.com/announcement/asx/1f72ae91ee9d37ca42e4773fe4c86fdc
    Progress Report
2022-04-08 08:20:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/f28728d88f1c5d9c2f554b1e2068570b
    Change in substantial holding
2022-04-28 08:22:00 Immutep to announce new TACTI-002 data at ASCO 2022 1 https://app.sharelinktechnologies.com/announcement/asx/6a4018ea9077b4ee73d3af85c1cc5b88
    Progress Report
2022-04-29 08:01:00 Quarterly Activities/Appendix 4C Cash Flow Report 1 https://app.sharelinktechnologies.com/announcement/asx/eb046cfd08aec55c17e993159ebe7bce
    Commitments Test Entity - Third Quarter Report
    Commitments Test Entity - Third Quarter Activity Report
2022-05-04 18:54:00 New & significant data from AIPAC phase 2b trial in MBC 1 https://app.sharelinktechnologies.com/announcement/asx/975a52853b5f99d7a10b6f39de1a7736
    Progress Report
2022-05-18 08:17:00 Leading Oncologists appointed to Clinical Advisory Board 0 https://app.sharelinktechnologies.com/announcement/asx/6a3553996eb9d9e634e0e7d6ef8e4716
    Company Administration - Other
2022-05-20 08:22:00 Immutep to Present at Investor Conferences 0 https://app.sharelinktechnologies.com/announcement/asx/95dfd2154220d2fd26a7b2cde8e3212b
    Company Administration - Other
    Web Casts
2022-05-24 17:28:00 Immutep Corporate Presentation 0 https://app.sharelinktechnologies.com/announcement/asx/60107de955fa3a8bf799dc41d173b819
    Company Presentation
2022-05-27 07:34:00 Immutep announces publication of ASCO 2022 abstracts 1 https://app.sharelinktechnologies.com/announcement/asx/136e46eeebc2fabb936a003316e758a7
    Progress Report
2022-06-02 08:17:00 Immutep webcast for TACTI-002 data presented at ASCO 2022 0 https://app.sharelinktechnologies.com/announcement/asx/8c2f91990c9b95c8620eb30b667feb03
    Company Administration - Other
    Web Casts
2022-06-06 08:20:00 Positive ORR in 1st line NSCLC from ph 2 TACTI-002 trial 1 https://app.sharelinktechnologies.com/announcement/asx/beacec2d1caa8a77a7f7de450280b3d1
    Progress Report
2022-06-06 09:04:00 Webcast slides for 1st line NSCLC data from TACTI-002 trial 1 https://app.sharelinktechnologies.com/announcement/asx/3f382e286c078a9bc7b763bb792ba094
    Company Presentation
    Progress Report
2022-06-17 12:38:00 Immutep Investor Update 0 https://app.sharelinktechnologies.com/announcement/asx/f447e117c86343cbba172650c0ee8c57
    Progress Report
2022-06-27 09:29:00 TACTI-002 lung cancer data to be presented at 2022 WCLC 0 https://app.sharelinktechnologies.com/announcement/asx/740c7d6cffde8f6a4d36acfb372090be
    Company Administration - Other
2022-07-06 08:22:00 Immutep granted Japanese Patent for IMP761 1 https://app.sharelinktechnologies.com/announcement/asx/7d50a77fae09d41cef180925833c7f10
    Progress Report
2022-07-14 17:25:00 Notification of cessation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/dadc1fb37494b82bffc75a36161221a4
    Appendix 3H (Notification of cessation of securities)
2022-07-28 10:07:00 Quarterly Activities/Appendix 4C Cash Flow Report 1 https://app.sharelinktechnologies.com/announcement/asx/c304e265b515f6aa2a41816255c12960
    Commitments Test Entity - Fourth Quarter Report
    Commitments Test Entity - Fourth Quarter Activity Report
2022-08-01 07:55:00 TACTI-002 2nd line lung cancer data presented at 2022 WCLC 1 https://app.sharelinktechnologies.com/announcement/asx/0c52e482e94f511fac55c5eb1a2d3e10
    Progress Report
2022-08-30 09:43:00 Japanese Patent Grant for efti, soluble LAG-3 with anti-PD-1 1 https://app.sharelinktechnologies.com/announcement/asx/4a40aa14896f3ca1a66f0659a2d6e481
    Progress Report
2022-08-31 17:35:00 Appendix 4E & 2022 Full Year Statutory Accounts 1 https://app.sharelinktechnologies.com/announcement/asx/cb8e5397db04324fb48e7da8f6d31bf2
    Annual Report
    Top 20 shareholders
    Preliminary Final Report
    Full Year Accounts
    Full Year Audit Review
    Full Year Directors' Statement
    Full Year Directors' Report
2022-09-06 09:21:00 New investigator-initiated ph2 trial in Soft Tissue Sarcoma 1 https://app.sharelinktechnologies.com/announcement/asx/d00c9f2272660883c307f038960e0f84
    Progress Report
2022-09-13 08:14:00 Immutep Appoints LAG-3 Pioneer Dr Frederic Triebel to Board 0 https://app.sharelinktechnologies.com/announcement/asx/d326a505a1b1d86fc2309da914b0af61
    Director Appointment/Resignation
2022-09-13 08:15:00 Initial Director's Interest Notice - Frederic Triebel 0 https://app.sharelinktechnologies.com/announcement/asx/357905d2026802d8270069f114d9bd55
    Initial Director's Interest Notice
2022-09-14 08:14:00 Clinical Development Update for Eftilagimod Alpha 1 https://app.sharelinktechnologies.com/announcement/asx/931279e6b68a18b20b1dfcd79ae522c1
    Progress Report
2022-09-21 09:09:00 2022 AGM & Key Dates 0 https://app.sharelinktechnologies.com/announcement/asx/e9c26029a04263697805cfc1a2cde699
    Notice of Meeting - Other
    Company Administration - Other
2022-09-23 09:09:00 Immutep Receives A$2.7 million R&D French Tax Incentive 1 https://app.sharelinktechnologies.com/announcement/asx/0f22d53d2d155d3bfa4c5b4149c06d28
    Periodic Reports - Other
2022-09-26 08:13:00 Immutep to Participate in Two Upcoming Investor Conferences 0 https://app.sharelinktechnologies.com/announcement/asx/408bc859f91089e959daa52d678f156d
    Company Administration - Other
    Web Casts
2022-09-30 10:47:00 Becoming a substantial holder from AEF 0 https://app.sharelinktechnologies.com/announcement/asx/5dcc96f94f75e96cbc0993312ac314ae
    Becoming a substantial holder
2022-10-03 11:49:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/abfe35d29a14505ccd900fe608d1c710
    Appendix 2A (Application for Quotation of Securities
2022-10-04 09:53:00 Fast Track granted by US FDA for Efti in 1st line NSCLC 1 https://app.sharelinktechnologies.com/announcement/asx/e5627a615154229054965736d323bc69
    Progress Report
2022-10-05 17:22:00 Change of Director's Interest Notice - F Triebel 0 https://app.sharelinktechnologies.com/announcement/asx/66c3c9397c2d64ab3596d8f6b155fbed
    Change of Director's Interest Notice
2022-10-05 17:24:00 Change of Director's Interest Notice - P Meyers 0 https://app.sharelinktechnologies.com/announcement/asx/fdb61f0ed43ca098e94a1621ec370bc4
    Change of Director's Interest Notice
2022-10-05 17:24:00 Change of Director's Interest Notice - M Voigt 0 https://app.sharelinktechnologies.com/announcement/asx/4d2c22bdf30cebebd711d495d70b245b
    Change of Director's Interest Notice
2022-10-06 08:14:00 Abstracts accepted for Presentation at SITC 2022 1 https://app.sharelinktechnologies.com/announcement/asx/2b1d43b0872d9ad7b491ee7abb35d67f
    Company Administration - Other
2022-10-06 11:07:00 Ceasing to be a substantial shareholder from AEF 0 https://app.sharelinktechnologies.com/announcement/asx/aa9a5304e2ef052830b4b5adcfaceb65
    Ceasing to be a substantial holder
2022-10-13 09:11:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/efe6b311f5c66c46976623d9d140d15f
    Appendix 2A (Application for Quotation of Securities
2022-10-18 08:08:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement/asx/180e5c65acdb7b237cfb8a200f0ef3f1
    Change in substantial holding
2022-10-21 14:21:00 Annual Report to shareholders 0 https://app.sharelinktechnologies.com/announcement/asx/774e126aab696d4995ca2d552c1d51d1
    Annual Report
    Top 20 shareholders
    Full Year Accounts
    Full Year Audit Review
    Full Year Directors' Statement
    Full Year Directors' Report
2022-10-21 14:26:00 Appendix 4G and Corporate Governance Statement 0 https://app.sharelinktechnologies.com/announcement/asx/9a2a14c0e21f855243443bb5ae401380
    Corporate Governance
    Takeover - Appendix 4G
2022-10-21 14:37:00 Notice of Annual General Meeting/Proxy Form 0 https://app.sharelinktechnologies.com/announcement/asx/793b723bb609d43c3504a86072718882
    Notice of Annual General Meeting
    Proxy Form
    Letter to Shareholders
2022-10-25 10:49:00 Quarterly Activities/Appendix 4C Cash Flow Report 1 https://app.sharelinktechnologies.com/announcement/asx/187d7cc57e9dab8627ae5b80cdf18560
    Commitments Test Entity - First Quarter Report
    Commitments Test Entity - First Quarter Activity Report
2022-10-26 09:36:00 Independent DMC recommends to continue TACTI-003 as planned 1 https://app.sharelinktechnologies.com/announcement/asx/224ac9ff944310f6193d97dcc87886d4
    Progress Report
2022-10-31 16:07:00 Change of Registry Address 0 https://app.sharelinktechnologies.com/announcement/asx/a01e374363e5cc65ca3af1b3a1f5536b
    Details of Share Registry address
2022-11-01 07:38:00 Annual Report filed on Form 20-F with SEC 0 https://app.sharelinktechnologies.com/announcement/asx/194814f898dc5107e4729ddf5f593d30
    Annual Report
2022-11-02 10:28:00 Immutep to Participate in Two Upcoming Investor Conferences 0 https://app.sharelinktechnologies.com/announcement/asx/da3a6319de72a581396f4dedcdba6a75
    Web Casts
2022-11-02 12:45:00 Immutep Corporate Presentation 0 https://app.sharelinktechnologies.com/announcement/asx/5fef6efd1493533ce144bd74634b5a6a
    Company Presentation
2022-11-03 08:33:00 Late Breaking Abstract accepted for SITC Oral Presentation 1 https://app.sharelinktechnologies.com/announcement/asx/ccf46a48c4a68cbbca02dc55fadd2581
    Progress Report
2022-11-04 09:08:00 Abstract for Efti selected for SITC 2022 Press Conference 0 https://app.sharelinktechnologies.com/announcement/asx/5221cdf354a31c13267296ee686a8c94
    Progress Report
    Web Casts
2022-11-09 15:33:00 New Patents Granted in Japan and South Korea for Efti 1 https://app.sharelinktechnologies.com/announcement/asx/068fedc0318485784684efa19c01a74b
    Progress Report
2022-11-11 08:16:00 Immutep Webcast to discuss clinical data presented at SITC 1 https://app.sharelinktechnologies.com/announcement/asx/734051b89c65d3a04bca9d512b7959ba
    Company Presentation
2022-11-11 08:16:00 TACTI-002 data presented at SITC for Efti in 1st line NSCLC 1 https://app.sharelinktechnologies.com/announcement/asx/1653d107c6f9fe9dd696cb9ab3d444a6
    Progress Report
    Company Administration - Other
2022-11-11 08:16:00 INSIGHT-003 triple combination data presented at SITC 2022 1 https://app.sharelinktechnologies.com/announcement/asx/87043c2acccb51885429641907d5f958
    Progress Report
    Company Administration - Other
2022-11-14 09:18:00 Immutep receives A$1 million R&D Tax Incentive 1 https://app.sharelinktechnologies.com/announcement/asx/9f8100325350b45d8cbd7be70dd7521d
    Periodic Reports - Other
    Company Administration - Other
2022-11-17 10:58:00 Immutep Investor Update 0 https://app.sharelinktechnologies.com/announcement/asx/adc9bce723c89ccbbe5df517e551349c
    Periodic Reports - Other
    Progress Report
2022-11-23 08:18:00 Immutep AGM 2022 - CEO's Presentation 0 https://app.sharelinktechnologies.com/announcement/asx/709b70e60c0f21511d5a43735c607919
    Company Presentation
    Chairman's Address to Shareholders
2022-11-23 08:18:00 Immutep AGM 2022 - Chairman's Address 0 https://app.sharelinktechnologies.com/announcement/asx/75157dc9a067bf299a342b0e443223c1
    Chairman's Address to Shareholders
2022-11-23 13:01:00 Results of Meeting 0 https://app.sharelinktechnologies.com/announcement/asx/447245742f18600a4fc3497aad43744b
    Results of Meeting
2022-11-29 08:14:00 Immutep enters 2nd collaboration with Pfizer and Merck KGaA 1 https://app.sharelinktechnologies.com/announcement/asx/469a79dcada667aa3934b29b4108ae7a
    Progress Report
2022-12-06 08:59:00 GMP Manufacturing Process Developed for IMP761 LAG-3 Agonist 1 https://app.sharelinktechnologies.com/announcement/asx/d4aa1386240d2cf4e7200d271fb29c6e
    Progress Report
2022-12-08 08:16:00 Commercial Scale in Manufacturing of Efti Achieved 1 https://app.sharelinktechnologies.com/announcement/asx/eea35e07c34d640e588c7f91a26377b6
    Progress Report
2022-12-15 11:09:00 Proposed issue of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/adf08ecc0d3ed5ffd9018ebb3d20fddd
    Appendix 3B
2022-12-16 15:25:00 Notification regarding unquoted securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/3fd9d44b6cf9cff9ab963e222384b06a
    Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2022-12-16 15:26:00 Notification regarding unquoted securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/a6bf3d2ed8cd838caf0f585ed68a0069
    Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2022-12-21 12:08:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement/asx/bbabb563bb8bea25d775dce7836abdb6
    Appendix 2A (Application for Quotation of Securities
2022-12-22 15:54:00 Change of Director's Interest Notice - R Howard 0 https://app.sharelinktechnologies.com/announcement/asx/605d8b4d19d316686dda8ef1b9783704
    Change of Director's Interest Notice
2022-12-22 15:56:00 Change of Director's Interest Notice - P Meyers 0 https://app.sharelinktechnologies.com/announcement/asx/9c82a5d7553194f767d6ae5fb6879602
    Change of Director's Interest Notice
2022-12-22 15:58:00 Change of Director's Interest Notice L Turnbull 0 https://app.sharelinktechnologies.com/announcement/asx/cef5cfb34bdf5ff6deec73d9e5687a2f
    Change of Director's Interest Notice
2022-12-23 13:00:00 Update on MBC trial design following successful FDA meeting 1 https://app.sharelinktechnologies.com/announcement/asx/9db9c27a2ba4d09307b52a86665cac74
    Progress Report
Powered by Share Link